Suppr超能文献

MIB1免疫阳性与垂体腺瘤的快速复发有关。

MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomas.

作者信息

Mizoue T, Kawamoto H, Arita K, Kurisu K, Tominaga A, Uozumi T

机构信息

Department of Neurosurgery, Hiroshima University School of Medicine, Japan.

出版信息

Acta Neurochir (Wien). 1997;139(5):426-31; discussion 431-2. doi: 10.1007/BF01808879.

Abstract

Pituitary adenomas are generally regarded as benign tumours, but they may recur. We identified eight patients with pituitary adenomas that showed rapid regrowth within 2 years of initial surgery. We estimated the percentage of cells in each specimen that showed positive immunostaining for MIB1 (a novel anti-Ki-67) and compared the values to those of 40 adenomas that showed no regrowth. The mean MIB1 index for 40 adenomas that showed no evidence of regrowth was 0.19 +/- 0.06%. This was significantly (p < 0.0001) lower than that for adenomas that showed rapid regrowth (1.27 +/- 0.31%), based on the initial resected specimens. Immediately after detection of rapid regrowth and in adenomas that were resistant to bromocriptine or irradiation, the MIB1 index was always greater than 1.0%. Most patients with rapidly regrowing adenomas were well controlled by radiation therapy. Our results suggest that a MIB1 index greater than 1.0% may be a useful predictor of rapid regrowth of pituitary adenomas and may be useful for planning of therapy.

摘要

垂体腺瘤通常被视为良性肿瘤,但可能会复发。我们确定了8例垂体腺瘤患者,这些患者在初次手术后2年内出现快速复发。我们估计了每个标本中对MIB1(一种新型抗Ki-67抗体)呈阳性免疫染色的细胞百分比,并将这些值与40例未复发的腺瘤的值进行比较。40例未显示复发迹象的腺瘤的平均MIB1指数为0.19±0.06%。根据最初切除的标本,这一数值显著低于快速复发腺瘤的数值(1.27±0.31%)(p<0.0001)。在检测到快速复发后以及对溴隐亭或放疗耐药的腺瘤中,MIB1指数始终大于1.0%。大多数快速复发腺瘤患者通过放射治疗得到了良好控制。我们的结果表明,MIB1指数大于1.0%可能是垂体腺瘤快速复发的有用预测指标,并且可能有助于治疗方案的制定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验